On the other hand, the expression level of SHMT2 in BLCA was significantly higher compared to normal bladder tissue (*P < 0.05, ***P < 0.001), and BLCA patients with high SHMT2 expression had significantly lower clinical survival time. The gene discussed is SHMT2; the disease is bladder transitional cell carcinoma.